Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway

PURPOSE: Cervical cancer is the fourth most common cancer in women worldwide and is the main cause of cancer-related deaths in women. Cisplatin (DDP) is one of the major chemotherapeutic drugs for cervical cancer patients. But, drug resistance limits the effectiveness of cancer therapy. Nucleolin (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Jing, Gu, Chunming, Zhang, Heyan, Liu, Yang, Zhang, Wenhao, Rao, Huiling, Li, Shan, Wu, Fuyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084676/
https://www.ncbi.nlm.nih.gov/pubmed/33976698
http://dx.doi.org/10.1155/2021/9992218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084676/
https://www.ncbi.nlm.nih.gov/pubmed/33976698
http://dx.doi.org/10.1155/2021/9992218

Ejemplares similares